{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T13:11:40Z","timestamp":1752671500216,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Science and Technology Department of Sichuan Province, China","award":["2020YFS0557"],"award-info":[{"award-number":["2020YFS0557"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00774-022-01340-8","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T04:02:36Z","timestamp":1653969756000},"page":"712-719","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between non-alcoholic fatty liver disease and bone turnover markers in southwest China"],"prefix":"10.1007","volume":"40","author":[{"given":"Ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6312-8955","authenticated-orcid":false,"given":"Dongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"key":"1340_CR1","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","volume":"56","author":"G Baffy","year":"2012","unstructured":"Baffy G, Brunt EM, Caldwell SH (2012) Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 56:1384\u20131391. https:\/\/doi.org\/10.1016\/j.jhep.2011.10.027","journal-title":"J Hepatol"},{"key":"1340_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E (2018) Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15:11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1340_CR3","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, Targher G (2017) Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 66:1138\u20131153. https:\/\/doi.org\/10.1136\/gutjnl-2017-313884","journal-title":"Gut"},{"key":"1340_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/396545","volume":"2013","author":"R Cui","year":"2013","unstructured":"Cui R, Sheng H, Rui X-F, Cheng X-Y, Sheng C-J, Wang J-Y, Qu S (2013) Low bone mineral density in Chinese adults with nonalcoholic fatty liver disease. Int J Endocrinol 2013:1\u20136. https:\/\/doi.org\/10.1155\/2013\/396545","journal-title":"Int J Endocrinol"},{"key":"1340_CR5","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s40618-015-0315-6","volume":"38","author":"G Targher","year":"2015","unstructured":"Targher G, Lonardo A, Rossini M (2015) Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link? J Endocrinol Invest 38:817\u2013825. https:\/\/doi.org\/10.1007\/s40618-015-0315-6","journal-title":"J Endocrinol Invest"},{"key":"1340_CR6","doi-asserted-by":"publisher","first-page":"e0197900","DOI":"10.1371\/journal.pone.0197900","volume":"13","author":"T Umehara","year":"2018","unstructured":"Umehara T (2018) Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: cross-sectional study in U.S. adults. PLoS One 13:e0197900. https:\/\/doi.org\/10.1371\/journal.pone.0197900","journal-title":"PLoS One"},{"key":"1340_CR7","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","volume":"36","author":"M Sasso","year":"2010","unstructured":"Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, Sandrin L, Miette V (2010) Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 36:1825\u20131835. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2010.07.005","journal-title":"Ultrasound Med Biol"},{"key":"1340_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/hmer.s7394","volume":"2","author":"S Mueller","year":"2010","unstructured":"Mueller S, Sandrin L (2010) Liver stiffness: a novel parameter for the diagnosis of liver disease. Hepat Med 2:49\u201367. https:\/\/doi.org\/10.2147\/hmer.s7394","journal-title":"Hepat Med"},{"key":"1340_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology 67:328\u2013357. https:\/\/doi.org\/10.1002\/hep.29367","journal-title":"Hepatology"},{"key":"1340_CR10","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O","year":"2016","unstructured":"European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O (2016) EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 64:1388\u20131402. https:\/\/doi.org\/10.1016\/j.jhep.2015.11.004","journal-title":"J Hepatol"},{"key":"1340_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3760\/cma.j.issn.1007-3418.2015.02.006","volume":"23","author":"X Ou","year":"2015","unstructured":"Ou X, Wang X, Wu X, Kong Y, Duan W, Zhou J, Sun D, Wang Y, You H, Jia J (2015) Comparison of FibroTouch and FibroScan for the assessment of fibrosis in chronic hepatitis B patients. Zhonghua Gan Zang Bing Za Zhi 23:103\u2013106. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2015.02.006","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"1340_CR12","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000323","volume":"12","author":"Y Qu","year":"2021","unstructured":"Qu Y, Song YY, Chen CW, Fu QC, Shi JP, Xu Y, Xie Q, Yang YF, Zhou YJ, Li LP, Xu MY, Cai XB, Zhang QD, Yu H, Fan JG, Lu LG (2021) Diagnostic performance of FibroTouch ultrasound attenuation parameter and liver stiffness measurement in assessing hepatic steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Clin Transl Gastroenterol 12:e00323. https:\/\/doi.org\/10.14309\/ctg.0000000000000323","journal-title":"Clin Transl Gastroenterol"},{"key":"1340_CR13","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jgh.12840","volume":"30","author":"J Jia","year":"2015","unstructured":"Jia J, Hou J, Ding H, Chen G, Xie Q, Wang Y, Zeng M, Zhao J, Wang T, Hu X, Schuppan D (2015) Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B. J Gastroenterol Hepatol 30:756\u2013762. https:\/\/doi.org\/10.1111\/jgh.12840","journal-title":"J Gastroenterol Hepatol"},{"key":"1340_CR14","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/hep.23312","volume":"51","author":"VW Wong","year":"2010","unstructured":"Wong VW, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, Choi PC, Kowo M, Chan AW, Merrouche W, Sung JJ, de Ledinghen V (2010) Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51:454\u2013462. https:\/\/doi.org\/10.1002\/hep.23312","journal-title":"Hepatology"},{"key":"1340_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/hep.23280","volume":"51","author":"E Fabbrini","year":"2010","unstructured":"Fabbrini E, Sullivan S, Klein S (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51:679\u2013689. https:\/\/doi.org\/10.1002\/hep.23280","journal-title":"Hepatology"},{"key":"1340_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1507\/endocrj.k10e-297","volume":"58","author":"YK Jeon","year":"2011","unstructured":"Jeon YK, Lee JG, Kim SS, Kim BH, Kim SJ, Kim YK, Kim IJ (2011) Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women. Endocr J 58:87\u201393. https:\/\/doi.org\/10.1507\/endocrj.k10e-297","journal-title":"Endocr J"},{"key":"1340_CR17","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/hep.21852","volume":"46","author":"J Collier","year":"2007","unstructured":"Collier J (2007) Bone disorders in chronic liver disease. Hepatology 46:1271\u20131278. https:\/\/doi.org\/10.1002\/hep.21852","journal-title":"Hepatology"},{"key":"1340_CR18","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/ajg.2016.51","volume":"111","author":"JE Nelson","year":"2016","unstructured":"Nelson JE, Roth CL, Wilson LA, Yates KP, Aouizerat B, Morgan-Stevenson V, Whalen E, Hoofnagle A, Mason M, Gersuk V, Yeh MM, Kowdley KV (2016) Vitamin D deficiency is associated with increased risk of non-alcoholic steatohepatitis in adults with non-alcoholic fatty liver disease: possible role for MAPK and NF-kappaB? Am J Gastroenterol 111:852\u2013863. https:\/\/doi.org\/10.1038\/ajg.2016.51","journal-title":"Am J Gastroenterol"},{"key":"1340_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157515","volume":"11","author":"D Wang","year":"2016","unstructured":"Wang D, Lin H, Xia M, Aleteng Q, Li X, Ma H, Pan B, Gao J, Gao X (2016) Vitamin D levels are inversely associated with liver fat content and risk of non-alcoholic fatty liver disease in a Chinese middle-aged and elderly population: the Shanghai Changfeng study. PLoS One 11:e0157515. https:\/\/doi.org\/10.1371\/journal.pone.0157515","journal-title":"PLoS One"},{"key":"1340_CR20","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1017\/S0007114516000386","volume":"115","author":"HL Zhai","year":"2016","unstructured":"Zhai HL, Wang NJ, Han B, Li Q, Chen Y, Zhu CF, Chen YC, Xia FZ, Cang Z, Zhu CX, Lu M, Lu YL (2016) Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study (survey on prevalence in east China for metabolic diseases and risk factors (SPECT-China)). Br J Nutr 115:1352\u20131359. https:\/\/doi.org\/10.1017\/S0007114516000386","journal-title":"Br J Nutr"},{"key":"1340_CR21","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1111\/liv.12312","volume":"34","author":"J Dasarathy","year":"2014","unstructured":"Dasarathy J, Periyalwar P, Allampati S, Bhinder V, Hawkins C, Brandt P, Khiyami A, McCullough AJ, Dasarathy S (2014) Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int 34:e118\u2013e127. https:\/\/doi.org\/10.1111\/liv.12312","journal-title":"Liver Int"},{"key":"1340_CR22","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00439-010-0881-9","volume":"128","author":"FX Bu","year":"2010","unstructured":"Bu FX, Armas L, Lappe J, Zhou Y, Gao G, Wang HW, Recker R, Zhao LJ (2010) Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects. Hum Genet 128:549\u2013556. https:\/\/doi.org\/10.1007\/s00439-010-0881-9","journal-title":"Hum Genet"},{"key":"1340_CR23","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00204-013-1191-5","volume":"88","author":"AK Nussler","year":"2014","unstructured":"Nussler AK, Wildemann B, Freude T, Litzka C, Soldo P, Friess H, Hammad S, Hengstler JG, Braun KF, Trak-Smayra V, Godoy P, Ehnert S (2014) Chronic CCl4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: a mouse model to analyse the liver-bone axis. Arch Toxicol 88:997\u20131006. https:\/\/doi.org\/10.1007\/s00204-013-1191-5","journal-title":"Arch Toxicol"},{"key":"1340_CR24","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1038\/ajg.2016.406","volume":"111","author":"YA Patel","year":"2016","unstructured":"Patel YA, Henao R, Moylan CA, Guy CD, Piercy DL, Diehl AM, Abdelmalek MF (2016) Vitamin D is not associated with severity in NAFLD: results of a paired clinical and gene expression profile analysis. Am J Gastroenterol 111:1591\u20131598. https:\/\/doi.org\/10.1038\/ajg.2016.406","journal-title":"Am J Gastroenterol"},{"key":"1340_CR25","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1161\/ATVBAHA.110.204859","volume":"30","author":"U Saleem","year":"2010","unstructured":"Saleem U, Mosley TH Jr, Kullo IJ (2010) Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 30:1474\u20131478. https:\/\/doi.org\/10.1161\/ATVBAHA.110.204859","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1340_CR26","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.metabol.2011.01.002","volume":"60","author":"A Tan","year":"2011","unstructured":"Tan A, Gao Y, Yang X, Zhang H, Qin X, Mo L, Peng T, Xia N, Mo Z (2011) Low serum osteocalcin level is a potential marker for metabolic syndrome: results from a Chinese male population survey. Metabolism 60:1186\u20131192. https:\/\/doi.org\/10.1016\/j.metabol.2011.01.002","journal-title":"Metabolism"},{"key":"1340_CR27","doi-asserted-by":"publisher","first-page":"19782","DOI":"10.3390\/ijms141019782","volume":"14","author":"JJ Liu","year":"2013","unstructured":"Liu JJ, Chen YY, Mo ZN, Tian GX, Tan AH, Gao Y, Yang XB, Zhang HY, Li ZX (2013) Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in adult males, South China. Int J Mol Sci 14:19782\u201319791. https:\/\/doi.org\/10.3390\/ijms141019782","journal-title":"Int J Mol Sci"},{"key":"1340_CR28","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1359\/jbmr.090315","volume":"24","author":"RR Recker","year":"2009","unstructured":"Recker RR, Marin F, Ish-Shalom S, Moricke R, Hawkins F, Kapetanos G, de la Pena MP, Kekow J, Farrerons J, Sanz B, Oertel H, Stepan J (2009) Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis. J Bone Miner Res 24:1358\u20131368. https:\/\/doi.org\/10.1359\/jbmr.090315","journal-title":"J Bone Miner Res"},{"key":"1340_CR29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00223-001-1034-x","volume":"69","author":"AK Srivastava","year":"2001","unstructured":"Srivastava AK, MacFarlane G, Srivastava VP, Mohan S, Baylink DJ (2001) A new monoclonal antibody ELISA for detection and characterization of C-telopeptide fragments of type I collagen in urine. Calcif Tissue Int 69:327\u2013336. https:\/\/doi.org\/10.1007\/s00223-001-1034-x","journal-title":"Calcif Tissue Int"},{"key":"1340_CR30","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.26355\/eurrev_201803_14493","volume":"22","author":"H Deng","year":"2018","unstructured":"Deng H, Dai Y, Lu H, Li SS, Gao L, Zhu DL (2018) Analysis of the correlation between non-alcoholic fatty liver disease and bone metabolism indicators in healthy middle-aged men. Eur Rev Med Pharmacol Sci 22:1457\u20131462. https:\/\/doi.org\/10.26355\/eurrev_201803_14493","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1340_CR31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1365-2265.2011.04035.x","volume":"75","author":"P Iglesias","year":"2011","unstructured":"Iglesias P, Arrieta F, Pi\u00f1era M, Botella-Carretero JI, Balsa JA, Zamarr\u00f3n I, Menacho M, D\u00edez JJ, Mu\u00f1oz T, V\u00e1zquez C (2011) Serum concentrations of osteocalcin, procollagen type 1 N-terminal propeptide and beta-CrossLaps in obese subjects with varying degrees of glucose tolerance. Clin Endocrinol 75:184\u2013188. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04035.x","journal-title":"Clin Endocrinol"},{"key":"1340_CR32","doi-asserted-by":"publisher","first-page":"9178616","DOI":"10.1155\/2021\/9178616","volume":"2021","author":"M Zhang","year":"2021","unstructured":"Zhang M, Nie X, Yuan Y, Wang Y, Ma X, Yin J, Bao Y (2021) Osteocalcin alleviates nonalcoholic fatty liver disease in mice through GPRC6A. Int J Endocrinol 2021:9178616. https:\/\/doi.org\/10.1155\/2021\/9178616","journal-title":"Int J Endocrinol"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-022-01340-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-022-01340-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-022-01340-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T03:30:31Z","timestamp":1657078231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-022-01340-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1340"],"URL":"https:\/\/doi.org\/10.1007\/s00774-022-01340-8","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"type":"print","value":"0914-8779"},{"type":"electronic","value":"1435-5604"}],"subject":[],"published":{"date-parts":[[2022,5,31]]},"assertion":[{"value":"21 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All procedures performed in this study involving human participants were in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the ethics committees of the Sichuan Provincial People\u2019s Hospital (No. 407(2020)) and exempted from the informed consent of the retrospective analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}